Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$19.89 - $30.02 $1.42 Million - $2.15 Million
-71,598 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$12.1 - $28.85 $786,500 - $1.88 Million
-65,000 Reduced 47.58%
71,598 $2.07 Million
Q1 2018

May 15, 2018

BUY
$5.18 - $7.97 $129,500 - $199,250
25,000 Added 22.4%
136,598 $1.09 Million
Q4 2017

Feb 14, 2018

SELL
$3.98 - $7.37 $232,432 - $430,408
-58,400 Reduced 34.35%
111,598 $819,000
Q3 2017

Nov 14, 2017

BUY
$1.33 - $4.12 $226,097 - $700,391
169,998
169,998 $629,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.33B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.